Lead Generation · Biotech & Life Sciences
Lead Generation for Biotech & Life Sciences
Qualified pipeline through paid acquisition, content marketing, ABM, and outbound prospecting. CRM-integrated and revenue-attributed. Investor relations, scientific communications, and growth marketing for biotech, pharma, medtech, and life sciences companies.
Book a 15-min strategy callThe Biotech & Life Sciences context
What lead generation means for biotech & life sciences companies
Biotech marketing in 2026 must respect SEC fair disclosure rules, FDA promotional restrictions, clinical trial blackout periods, and MLR (Medical/Legal/Regulatory) review processes. Long timelines (pre-clinical to commercial: 7-15 years) require sustained narrative investment without short-term traffic metrics as proof.
Empire325 B2B lead generation services build qualified-pipeline programs across paid acquisition, content marketing, account-based marketing (ABM), and outbound prospecting — measured to closed-won revenue, not vanity MQL counts.
Biotech & Life Sciences is a regulated sector, which materially changes how lead generation engagements have to be structured. Empire325 operates within the applicable compliance framework (U.S. Food and Drug Administration guidance, supervisory review, and documented approval workflows) rather than around it. Programs are co-designed with your compliance counsel and chief compliance officer so that creative, distribution, measurement, and reporting all survive an audit. This is materially different from generic agency engagements that treat compliance as an afterthought and produce campaigns that get retroactively pulled or restricted.
For the canonical industry framing, see U.S. Food and Drug Administration — Empire325 references that source-of-truth when building the measurement, attribution, and compliance baseline for every biotech & life sciences lead generation engagement. The methodology layer above it draws on LinkedIn Marketing Solutions and our own production patterns from prior biotech & life sciences engagements.
Capabilities
Lead Generation capabilities for biotech & life sciences clients
Why Empire325
Why Empire325 for biotech & life sciences lead generation
Empire325 biotech marketing combines IR, scientific communications, KOL engagement, and commercial-readiness marketing — built alongside your regulatory and legal counsel. Scientific accuracy under MLR review, Reg-FD-aligned investor communications.
Measured outcomes
What biotech & life sciences clients achieve
2-3x qualified pipeline growth in 6 months
CAC payback period: 22 → 13 months
Closed-won revenue attribution by channel
Integrated demand + lead programs
FAQ — Lead Generation for Biotech & Life Sciences
Does Empire325 provide lead generation for biotech & life sciences companies?
Yes. Empire325 delivers lead generation specifically calibrated for biotech & life sciences companies. Empire325 biotech marketing combines IR, scientific communications, KOL engagement, and commercial-readiness marketing — built alongside your regulatory and legal counsel. Scientific accuracy under MLR review, Reg-FD-aligned investor communications.
What makes lead generation different for biotech & life sciences vs. other industries?
Biotech marketing in 2026 must respect SEC fair disclosure rules, FDA promotional restrictions, clinical trial blackout periods, and MLR (Medical/Legal/Regulatory) review processes. Long timelines (pre-clinical to commercial: 7-15 years) require sustained narrative investment without short-term traffic metrics as proof. Empire325 applies lead generation methodology with these industry-specific constraints and opportunities built in — not as an afterthought.
How much does lead generation cost for biotech & life sciences companies?
Lead Generation engagements for biotech & life sciences clients typically range from $10K–$60K monthly retainers depending on scope, team size, and market reach. Empire325 provides written scoping after a 30-minute discovery call. Most engagements deliver first measurable outcomes within 60–90 days.
Why choose Empire325 for biotech & life sciences lead generation?
Empire325 biotech marketing combines IR, scientific communications, KOL engagement, and commercial-readiness marketing — built alongside your regulatory and legal counsel. Scientific accuracy under MLR review, Reg-FD-aligned investor communications. Empire325's lead generation practice combines technical depth with biotech & life sciences-specific domain knowledge — so the work lands in your market, not just in a generic framework.
References & further reading
Sources cited on this lead generation for biotech & life sciences page
- LinkedIn Marketing Solutions — LinkedIn Marketing Solutions 2025 B2B benchmark report on lead-to-customer conversion.
- U.S. Food and Drug Administration — FDA Center for Drug Evaluation and Research promotional-communications guidance.
- Harvard Business Review — Harvard Business Review research on industry-specific marketing strategy and ROI benchmarks.
Need lead generation for your biotech & life sciences company?
15-minute strategy call. No deck, no pitch — specific recommendations based on your context.
Book a 15-min strategy call